New rotator cuff repair tech: Atreon Orthopedics gets FDA 510(k) clearance and full market launch of BioCharge® Autobiologic Matrix
Colombus-based Atreon Orthopedics says they’ve received 510(k) clearance from the FDA for its BioCharge® Autobiologic Matrix. This bioresorbable synthetic implant is designed to address biological failure modes in rotator cuff repair, potentially improving repair integrity and long-term patient outcomes. Send me the newsletter, I agree to the privacy policy*Yes Subscribe Send me the newsletter, I […]
Colombus-based Atreon Orthopedics says they’ve received 510(k) clearance from the FDA for its BioCharge® Autobiologic Matrix.
This bioresorbable synthetic implant is designed to address biological failure modes in rotator cuff repair, potentially improving repair integrity and long-term patient outcomes.
BioCharge Design and Functionality
BioCharge is an onlay scaffold with the following objectives:
- Kickstart the Patient’s Natural Healing Response: The company states that the implant wicks active biology at the tendon’s bursal side of the rotator cuff repair.
- Promote Cellular Activity: According to Atreon, the implant encourages native collagen remodeling and deters scar tissue formation.
- Reinforce the Suture-Tendon Interface: The company aims to minimize the risk of suture cut-through failure.
Simplified Arthroscopic Technique
“The BioCharge implant was designed with user-friendliness and superior performance as a top priority,” explained Shariff K. Bishai, DO, an orthopedic surgeon and founder of Detroit Orthopaedic Institute. “By integrating the delivery and fixation system into the design, we eliminated the need for cumbersome staple deployment found in current devices on the market. Streamlining this procedure, coupled with its safe and effective synthetic technology ensures greater repair consistency and lower costs. Having used BioCharge during the limited market launch, I’m pleased to report that at 5 months post-op, all my patients are thriving with no adverse events and I look forward to tracking their long-term clinical success.”
Here’s a video of the tech in action:
Setting a New Standard in Rotator Cuff Repair
Atreon reports that its electrospun nanofiber platform technology distinguishes itself from traditional augment devices, which rely on animal-processed collagen or human dermal allografts. These traditional methods carry inherent patient compatibility risks and have a costly manufacturing process. Atreon claims that its design, based on 17 years of tissue remodeling research, mimics the natural structure of tissues and drives cellular attachment and proliferation more effectively than leading collagen-based products. The resorption process of the fibers poly(glycolic acid) (PGA) and poly(lactide-co-caprolactone) (PLCL) is reported to offer benefits to the healing cascade, including anti-inflammatory effects, enhanced vascular remodeling, and accelerated cellular migration.
“With BioCharge, Atreon continues to set a new standard in rotator cuff repair,” said Brian Badman, M.D., an orthopedic surgeon at Central Indiana Orthopedics, IN. “For complex tears, I can now use the ROTIUM inlay combined with BioCharge onlay using Atreon’s BioStack Kit, providing versatile, biologic-driven solutions for improved patient outcomes.”
Availability and Further Information
Atreon’s BioCharge Autobiologic Matrix is now available across the US. For more information about Atreon’s technologies, here’s their site, and the company will be at the AAOS meeting in San Diego from March 9-12, booth #2043.
About Atreon Orthopedics
Atreon Orthopedics, LLC, is a start-up in the field of tissue regeneration, focusing on developing biologic solutions for orthopedic applications. By combining advanced materials science with biologic expertise, Atreon aims to pioneer a new era of orthopedic care to improve healing and help patients return to active lifestyles faster and with more reliable long-term results.
